The Results of Treatment of Basocellular Carcinomas of the Head Skin
Darko Lukic, Reuf Karabeg, Pavle Jeremic, Jadran Bandic, Malik Jakirlic, Nenad Babic, Amela Karabeg, Sanja Sibincic, Predrag Lazic
Med Arh. 2012; 66(3): 169-172
Introduction: Basocellular skin carcinoma (BCC) is the most common cancer in the human population. BCC almost appeared at adult’s people, but it can be found at children, too. The aim: The aim of this study was to determine which the position of BCC on the head skin is the most difficult for the treatment and what the reasons are for it. Methods: With the prospective study, from June 2004 to June 2011, were compared the results of treatment of basocellular carcinomas (BCC) of the head skin. The examinees were divided into 3 groups. The first group, the group A (38 patients) was consisted of examinees treated of BCC on the nose. In the second group, the group B (42 patients) was classified of examinees treated of BCC on the face, temple, eyelids and forehead, while the third group, group C (35 patients) was classified of examinees treated of BCC on the scalp. The parameters for comparison the results of treatment were the method of treatment, number of the relapse, elapsed time from surgery to relapse and consequently defacement. Results: There was found a statistical significant difference in terms of choice of methods of operative treatment for the significantly higher number of operations on the scalp operated with cutaneous transplants. It was confirmed that the localization of the tumors on the scalp, and then on the nose are with the highest incidence of the relapse, whereas the post-operative defacement is mostly on the scalp after skin graft placement.
1. Rogers HW, Weinstock MA, Harris AR. Incidence estimate of nonmelanoma skin cancer in the United States, (2006). Arch Dermatol. 2010; 283: 287.
2. Oprić M, Babić M, Granić V. Tumori mekih tkiva i kože, Elit Medica, Beograd, 1999.
3. Lukić D. Tumori kože.Medicinski fakultet Banja Luka, 2010: 45: 52.
4. Lukić D, Bandić J, Ivić D. Rezultati lečenja planocelularnog i bazocelularnog karcinoma kože glave i vrata i drugih anatomskih regija. Medicinska istraživanja, 2006: 40(1): 29-35.
5. Anwar U, Ghazal ASK, Ahmad M, Sharpe DT. Horrifying basal cell carcinoma forearm lesion leading to shoulder disarticulation. Plast Reconstr Surg. 2006; 117-119.
6. Asilian A, Tamizifar B. Aggressive and neglected basal cell carcinoma. Dermatologic Surgery. 2005; 31(11, Pt.1): 1468-1471.
7. Braun-Falco O, Plewig G, Wolff HH, Winkeimann RK. Malignant epithelial tumors. In: Braun Falco O, Plewig G, Wolff HH, Winkeimann RK. (Ed.) Dermatology, Berlin: Springer-Verlag, 1991: 1018-1135.
8. Deo SV, Hazarika S, Shukla NK, Kumar S, Kar M, Samaiya A. Surgical management of skin cancers: Experience from a regional cancer centre in North India. Indian journal of cancer. 2005; 42(3): 145-150.
9. Eisner JM, Russell M. Cartilage hair hypoplasia and multiple basal cell carcinomas. J Am Acad Dermatol. 2006: 54-58.
10. Hutcheson AC, Fisher AH, Lang PG. Basal cell carcinomas with unusual histologic patterns. Journal of the American Academy of Dermatology. 2005; 53(5): 833.
11. McCutcheon B, White K, Kotwall C, Germolic D, Rebolloso Y, Hamann MS, Stiles A. A preliminary study of imiquimod treatment in variants of basal cell carcinoma. Am Surg. 2005; 71(8): 662-665.
12. Pennington BE, Leffe DJ. Mohs micrographic surgery: Established uses and emerging trends. Oncology, Willston Park, Aug. 2005; 19(9): 1165-1171.
13. Rončević R, Aleksić V, Stojičić M, Jovanović M, Rončević D. Invasive, aggresive basal cell carcinoma: Carcinoma basocellulare terebrans. European Journal of Plastic Surgery. 2006; 23: 379-384.